Delapril/indapamide

Drug Profile

Delapril/indapamide

Alternative Names: Delapride

Latest Information Update: 01 May 2003

Price : $50

At a glance

  • Originator Chiesi
  • Class Antihypertensives; Indans; Indoles; Sulfonamides
  • Mechanism of Action ACE inhibitors; Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 01 May 2003 A study has been added to the adverse events and Hypertension therapeutic trials sections
  • 10 Sep 2002 A study has been added to the adverse events and Hypertension therapeutic trials sections
  • 17 Dec 1997 Launched for Hypertension in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top